Indeed, epistaxis and mucocutaneous telangiectasia, hallmark features of HHT, have also been reported in a subset of CM-AVM patients, especially those with EPHB4 mutations [1, 3, 5, 9, 11, 36–38] (Fig. 3). This evidence concerns the gene EPHB4 and hereditary hemorrhagic telangiectasia.